| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 2Small sample | 100.0% (2/2) | 0.0% (0/2) | -0.4% | -0.4% | -0.4% |
| 20D | 2Small sample | 100.0% (2/2) | 0.0% (0/2) | -1.1% | -1.1% | -1.1% |
| 60D | 2Small sample | 100.0% (2/2) | 0.0% (0/2) | -8.9% | -8.9% | -8.9% |
| 120D | 0No data | Awaiting maturity | — | — | — | — |
COMPANY RESEARCH
EMEIS
EMEIS.PA · France · Healthcare · Medical Care Facilities
INSIDER SIGNAL
Insider activity score：51.9 / 100
2 insiders · 4 purchase events · €179k net purchases
Europe #569 · France #55
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
Cluster+21.0 / 35
How many distinct insiders bought in the cluster
Purchase size+19.6 / 25
Purchase value relative to company size and liquidity
Role+20.0 / 20
The seniority and relevance of participating insiders
Recency+1.3 / 10
How recently the purchases occurred
Conviction+10.0 / 10
How clearly buying stands out from other activity
What is holding the score back?
- ⚠ Buyer breadth is moderate · fewer than 4 distinct filers
- ⚠ Purchase activity is becoming less recent
- ✓ Strong insider role · ceo/chair involved
The role contribution uses the inverted role input of the current European model.
Buying concentration
73%
Largest buyer：Laurent GUILLOT · 131k EUR
Gross qualified purchase transaction-line value：179k EUR
The headline € total is net buying for the screen; this module uses gross qualified purchase transaction-line values in the filing currency, so the amounts can differ. The current 15-day buyer-breadth input counts distinct buyers; value concentration is disclosed separately here.
This is a ranking under the current European screening rules—not a probability of gain, return forecast, or buy recommendation.
Key purchase quotes (filing currency)
| Filer | Price per unit | Trade date |
|---|---|---|
| Laurent GUILLOT | 11.9758 EUR | Sep 18, 2026 |
| JEAN-MARC BOURSIER | 13.89 EUR | Jun 22, 2026 |
| Laurent GUILLOT | 14.1584 EUR | Jun 9, 2026 |
Model details
Cluster breakdown (does not change the score)
- 15-day buyer breadth (count)
- 2 distinct reported filers
- Peak time window
- 2026-06-09 to 2026-06-22
- Current breadth input
- 0.600 (capped at 4+ buyers)
- Buyer independence
- Not yet measured; related-party fields are not cross-market comparable
What the filings show
- 🟢 Recent eligible purchase
Laurent GUILLOT · 60k EUR · Price 11.9758 EUR · Sep 18, 2026 - 🟢 Eligible purchase
JEAN-MARC BOURSIER · 21k EUR · Price 13.89 EUR · Jun 22, 2026 - 🟢 Large eligible purchase
Laurent GUILLOT · 71k EUR · Price 14.1584 EUR · Jun 9, 2026 - 🟡 2 remaining qualified transaction line(s) across 2 disclosure(s)
Insider vs stock price
4 purchase day(s), 5 purchase line(s) in the 180-day window.
Daily close (EUR)Day with an insider purchase
Markers sit on the closing price of the transaction day. They show when insiders traded, not the price they paid or received. "Since" compares that day's close with the last close shown; it is what happened at this company, not a forecast.
If you had followed the purchase
Each row starts on the first close on or after the day a purchase was made public, the earliest a reader could have acted, and ends on the last close shown above.
| Made public | Insiders | In this stock, now | In the median peer stock, now | Difference |
|---|---|---|---|---|
| 2026-06-15 | 1 | 713 −28.7% | 918 −8.2% | −205 −20.5 pts |
| 2026-06-23 | 1 | 732 −26.8% | 941 −5.9% | −209 −20.9 pts |
| 2026-09-22 | 1 | 856 −14.4% | 948 −5.2% | −93 −9.3 pts |
0 of 3 disclosure day(s) ended ahead of the median peer stock.
Close to close, before costs, taxes, dividends and currency moves. The peer is the median of the other stocks on the same exchange for which this site holds prices (103 here), not an index. This is what happened, not a forecast: across all purchases on this site the typical gap is close to zero.
Insider timeline
2 insiders bought within 14 days, 9 Jun to 22 Jun: 2 CEO / chair. 1 of them bought again later. The share closed at 14.01 on the first of those days and at 10.25 most recently (−26.8%). That week 237 companies across Europe disclosed insider purchases, more than in 81% of the last 26 weeks: insiders often buy together when a closed period ends, so the timing alone says less than it seems.
Tap an item for what it means.
●A purchase: the bigger the dot, the more was bought
Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.
▮Purple band: several insiders bought within 15 days
The band marks the stretch with the most different buyers: at most 15 days long and at least two people. Here it is 9 Jun – 22 Jun, with 2 insiders. Only the strongest stretch is marked. Several people deciding the same thing is harder to explain by one person's private reasons, but insiders often buy together just after a closed period ends, so compare it with the grey weekly bars.
Blue line: this share's price, −25.3% over these six months
The closing price of each day, from 13.73 on 2026-04-21 to 10.25 on 2026-10-07. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.
Dashed line: the typical stock on the same exchange, −10.5%
Taken from the 104 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share −25.3%, the typical one −10.5%, 14.8 points behind. It is not an index and not a comparison within one industry.
▂Grey bars: companies across Europe disclosing purchases each week
A taller bar is a week in which more companies disclosed insider purchases. The purple bar is the week of the band above: 237 companies, number 4 of the last 26 weeks. If that week was a peak anyway, buying together is less special than it looks.
This company: insiders buying per month, last 12 months
Nov
Dec
Jan
Feb
Mar
Apr
May
2Jun
Jul
Aug
1Sep
Oct
Darker bars are inside the 180-day window above.
Who traded
| Insider | Role | Purchases | Sales | Bought | First purchase | Share price since | Earlier purchases |
|---|---|---|---|---|---|---|---|
| Laurent GUILLOT | CEO / chair | 2 | — | 130.7k EUR | 2026-06-09 | −26.8% | fewer than 5 completed |
| JEAN-MARC BOURSIER | CEO / chair | 2 | — | 48.1k EUR | 2026-06-18 | −24.1% | fewer than 5 completed |
Why this score? · Model details
Priority = 100 × Σ(fixed weight × 0–1 rule-based input)
| Factor | Weight | This company input | Point contribution |
|---|---|---|---|
| 15-day buyer breadth (count) | 35% | 0.600 | 21.0 |
| Qualified-buy size | 25% | 0.784 | 19.6 |
| Role informativeness (inverted) | 20% | 0.000 | 0.0 |
| Recency | 10% | 0.134 | 1.3 |
| Buy/sell conviction | 10% | 1.000 | 10.0 |
This is a heuristic ordering under the current rules, not a calibrated return forecast. It explains why candidates rank differently; the public-filing evidence and data limits are shown below.
BULL VS BEAR
Two readings of this buying
The same filings, read two ways. Each line is a fact stored for this company with the number behind it, and appears only when that number crosses a fixed threshold. Neither side is a forecast and no winner is declared.
Since 2026-10-13, neither column has changed. All bull and bear lists, and what followed each line in the past →
Where the evidence comes from
The two kinds of evidence disagree: the purchases themselves carry bull lines (more buyers than usual here, senior executive buying), while company results argue against (loss-making). No data is held for: company actions.
- The insider purchases themselvesBullmore buyers than usual here, senior executive buying6 checked, under the threshold · 4 missing
- Share price and trading2 checked, under the threshold
- Short sellers1 checked, under the threshold
- Company resultsBearloss-making1 missing
- Company actionsno data held
Bull case · the buying is informative
- No insider bought in the 180 days before this window; 2 have bought in it. The buying is new for this company, not a habit.Record: after 3,134 earlier disclosures like this, the median 60-session excess return was −2.7%, within 1 percentage point of all comparable disclosures (−2.7%).
- The buyers include the CEO or chair, who sees more of the business than most filers. This site's score gives little or no credit for that: in its backtests purchases by senior executives did no better than other insiders' purchases.Record: after 8,797 earlier disclosures like this, the median 60-session excess return was −3.1%, within 1 percentage point of all comparable disclosures (−3.2%).
Bear case · discount it
- Company resultsThe company is loss-making on the latest captured figures: profit margin −3.4%, return on equity −11%.
Evidence still missing
- The latest purchase (2026-09-18) falls within 30 days before the next scheduled results (2026-09-23), normally a closed period. Either the dealing was cleared as an exception or the results date is wrong; the filing and the financial calendar show which.
- No buyer here has 5 or more completed earlier purchases on record, so there is no track record to weigh.
- Only one reading of profitability is held (profit margin −3.4%). Whether earnings and cash flow are rising or falling needs the last two reports side by side.
- European notifications have no field saying whether a purchase was pre-arranged; there is no counterpart to the US 10b5-1 box. None of the 5 purchase lines mentions a plan, but a bare “Acquisition” does not rule one out.
- The filings give the size of each trade, not what the buyer already held. Whether a purchase added 1% to a personal stake or doubled it is not known.
Checked and under the threshold: 9, 5 close to it
- BullAt most 2 insiders bought within any 15 days. Counted for the bull side from 3. close to the threshold
- BearThe largest buyer accounts for 73% of the value bought. Counted for the bear side from 80%. close to the threshold
- EitherNet purchases equal 0.01% of the company's market value. Bull from 0.10%, bear below 0.01%. close to the threshold
- BearThe share price changed −15% over six months (three months −25%, one month −13%) and stands 32% below its 52-week high. Counted for the bear side from a fall of 20%. close to the threshold
- BearOver three months the share price changed −25% and the median of 271 Healthcare companies changed −6.3%: behind by 18 points. Counted for the bear side from 20 points behind. close to the threshold
- Bear0 of 2 buyers filed as a person closely associated with a manager. Counted for the bear side from half.
- BearNo insider sale is recorded in the same 180 days.
- EitherThe latest purchase is 29 days old. Bull up to 14 days, bear from 90.
- BearThe register of AMF shows no published net short position in this company. Positions under 0.5% are never published, so this does not show that nobody is short.
Both columns arrange stored facts only. They do not change the insider score or the ranking and are not investment advice.
Signal history
51.9 / 100
Latest recorded score
↑ +1.9 ptsversus the comparable snapshot on 2026-09-14 (34 calendar days apart)
- Recorded snapshots
- 35
- First snapshot
- 2026-08-26
Only scores captured when the scoring run completed are compared. These are raw signal scores saved when each full scoring run completed. They describe changes in research ranking, not price performance or returns.
Why did it change?
Decomposition across the five score factors between comparable snapshots; historical scores are not recalculated.
- Purchase size+0.7 pts
- Recency+1.3 pts
Signal score history
Fixed 0–100 scale; dates are spaced by calendar time.
Recent recorded points
- 50.3
- 50.0
- 55.6
- 53.3
- 51.9
View all recorded scores
| Snapshot date | Signal score |
|---|---|
| 2026-08-26 | 50.3 |
| 2026-08-27 | 50.3 |
| 2026-08-28 | 50.0 |
| 2026-08-31 | 50.0 |
| 2026-09-01 | 50.0 |
| 2026-09-02 | 50.0 |
| 2026-09-03 | 50.0 |
| 2026-09-04 | 50.0 |
| 2026-09-07 | 50.0 |
| 2026-09-08 | 50.0 |
| 2026-09-09 | 50.0 |
| 2026-09-10 | 50.0 |
| 2026-09-11 | 50.0 |
| 2026-09-14 | 50.0 |
| 2026-09-23 | 57.7 |
| 2026-09-24 | 57.2 |
| 2026-09-25 | 56.8 |
| 2026-09-28 | 55.6 |
| 2026-09-29 | 55.3 |
| 2026-09-30 | 55.0 |
| 2026-10-01 | 54.7 |
| 2026-10-02 | 54.4 |
| 2026-10-03 | 54.4 |
| 2026-10-04 | 54.4 |
| 2026-10-05 | 53.7 |
| 2026-10-06 | 53.5 |
| 2026-10-07 | 53.3 |
| 2026-10-08 | 53.1 |
| 2026-10-09 | 52.9 |
| 2026-10-12 | 52.5 |
| 2026-10-13 | 52.4 |
| 2026-10-14 | 52.3 |
| 2026-10-15 | 52.1 |
| 2026-10-16 | 52.0 |
| 2026-10-18 | 51.9 |
Sector context
- Buying breadth
- 6.1% (48 / 792 issuers)
- Sector rank
- #11 / 12
- 7D breadth change
- -0.4 pp · vs 2026-10-12 (6d)
- 30D breadth change
- History building
This is sector-level research context. It does not affect the Insider Signal or ranking.
Insider profile outcomes
Historical performance following insider filings. The company role is translated below each name while preserving the original title.
- Excess return = stock return − CAC 40 return over the same period.
- Hit rate = completed events with positive excess return ÷ total completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
- Small-sample rule: n<5 is shown for transparency and is not scored.
Events are disclosure-level observations; related disclosures published on the same date may share a return path and may not be statistically independent. This research enrichment does not affect the insider score or ranking.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 2Small sample | 100.0% (2/2) | 50.0% (1/2) | -2.9% | -2.9% | -8.0% |
| 20D | 1Small sample | 100.0% (1/1) | 100.0% (1/1) | +2.9% | +2.9% | +2.9% |
| 60D | 1Small sample | 100.0% (1/1) | 0.0% (0/1) | -6.4% | -6.4% | -6.4% |
| 120D | 0No data | Awaiting maturity | — | — | — | — |
Market context
PRICE PERFORMANCE
VOLATILITY & LIQUIDITY
- Volatility
- 44.0%
- Beta
- 0.63
- Avg daily volume
- €2.0M
VALUATION
- Market cap
- €1.8B
- P/E
- —
FUNDAMENTALS
- Profit margin
- -3.4%
- ROE
- -10.6%
- Industry
- Medical Care Facilities
Prices to 28 Sep 2026: OpenBB/yfinance. From OpenBB/yfinance, captured 28 Sep 2026: Market cap, Profit margin, ROE, Beta, Industry. It does not affect the insider score or rank.
Disclosed net short positions
The AMF register, read 18 Oct 2026, publishes no net short position of 0.5% or more in this issuer. Positions below 0.5% are never published, so this is not evidence that nobody is short.
Short-position disclosures are external context; they do not affect the insider score, ranking, or filing eligibility.
Insiders' buying price vs the latest close
The latest close in the price history is more than a week old.
Buying size vs market trading
Market history is too old for this snapshot; ratios are withheld.
Market-data coverage: 249 verified sessions · Latest session: 2026-10-07 · Ratio status: Unavailable
Traded value is estimated as close × shares traded, in major currency units. Includes disclosed qualifying purchases; disclosures may lag. Contractual or planned acquisitions are not necessarily discretionary. Ratios describe relative trading size, not market participation or score contributions.
Latest news
No news has been captured for this company.
Regulatory filings
The filing records held for this company carry no link to the original notice.
Filing evidence
These are underlying national-feed records from the 365-day window ending on the saved ranking snapshot. The score uses only the latest 180 days; older qualifying equity purchases remain visible for audit but do not enter the current score. The original filer, role, transaction classification, instrument, price, volume, value and source fields are retained. The first three rows are shown; remaining records can be unfolded for audit. Other transaction types are retained but excluded from the score.
Excluded transactions & classification
5 qualifying purchase disclosure(s) · 5 transaction line(s)
Sep 18, 2026Acquisition
Laurent GUILLOT · Directeur Général
Action · 5000.0000 shares × 11.9758 EUR · —
Jun 22, 2026Acquisition
JEAN-MARC BOURSIER · Directeur général adjoint
Action · 1500.0000 shares × 13.8900 EUR · —
Jun 18, 2026Acquisition
JEAN-MARC BOURSIER · Directeur général adjoint
Action · 1000.0000 shares × 13.5400 EUR · —
Unfold all 2 remaining filing row(s)
| Transaction date | Published | Filer | Role | Transaction | Instrument | Price (local currency) | Quote currency | Volume | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | 2026-06-23 | JEAN-MARC BOURSIER | Directeur général adjoint | Acquisition | Action | 13.7000 EUR | EUR | 1000.0000 | — |
| 2026-06-09 | 2026-06-15 | Laurent GUILLOT | Directeur Général | Acquisition | Action | 14.1584 EUR | EUR | 5000.0000 | — |
Showing 5 of 5 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level € aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Other disclosed transactions · excluded from score
The underlying filing feed is unavailable in this snapshot; this is not a claim that no filings exist.
Snapshot & identity
- Snapshot date
- 2026-10-18
- Ticker
- EMEIS.PA
- ISIN
- FR001400NLM4
- Sector
- Healthcare
- Industry
- Medical Care Facilities
Company logos by Parqet